nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—migraine—Acetylsalicylic acid—coronary artery disease	0.577	1	CpDpCtD
Tizanidine—CYP1A2—Gemfibrozil—coronary artery disease	0.0305	0.436	CbGbCtD
Tizanidine—CYP1A2—Clopidogrel—coronary artery disease	0.0264	0.378	CbGbCtD
Tizanidine—CYP1A2—Losartan—coronary artery disease	0.0129	0.185	CbGbCtD
Tizanidine—Clonidine—SLC22A3—coronary artery disease	0.000946	1	CrCbGaD
Tizanidine—Somnolence—Losartan—coronary artery disease	6.48e-05	0.000252	CcSEcCtD
Tizanidine—Dizziness—Eplerenone—coronary artery disease	6.47e-05	0.000252	CcSEcCtD
Tizanidine—Rash—Clopidogrel—coronary artery disease	6.47e-05	0.000252	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	6.47e-05	0.000252	CcSEcCtD
Tizanidine—Dermatitis—Clopidogrel—coronary artery disease	6.47e-05	0.000251	CcSEcCtD
Tizanidine—Asthenia—Valsartan—coronary artery disease	6.46e-05	0.000251	CcSEcCtD
Tizanidine—Hypertension—Timolol—coronary artery disease	6.46e-05	0.000251	CcSEcCtD
Tizanidine—Constipation—Furosemide—coronary artery disease	6.46e-05	0.000251	CcSEcCtD
Tizanidine—Hypersensitivity—Niacin—coronary artery disease	6.45e-05	0.000251	CcSEcCtD
Tizanidine—Ill-defined disorder—Lisinopril—coronary artery disease	6.44e-05	0.00025	CcSEcCtD
Tizanidine—Discomfort—Ramipril—coronary artery disease	6.44e-05	0.00025	CcSEcCtD
Tizanidine—Asthenia—Olmesartan—coronary artery disease	6.43e-05	0.00025	CcSEcCtD
Tizanidine—Rash—Lovastatin—coronary artery disease	6.43e-05	0.00025	CcSEcCtD
Tizanidine—Dermatitis—Lovastatin—coronary artery disease	6.42e-05	0.00025	CcSEcCtD
Tizanidine—Anaemia—Lisinopril—coronary artery disease	6.41e-05	0.000249	CcSEcCtD
Tizanidine—Dyspepsia—Losartan—coronary artery disease	6.41e-05	0.000249	CcSEcCtD
Tizanidine—Feeling abnormal—Perindopril—coronary artery disease	6.4e-05	0.000249	CcSEcCtD
Tizanidine—Pruritus—Valsartan—coronary artery disease	6.37e-05	0.000248	CcSEcCtD
Tizanidine—Dry mouth—Ramipril—coronary artery disease	6.37e-05	0.000248	CcSEcCtD
Tizanidine—Arthralgia—Timolol—coronary artery disease	6.37e-05	0.000248	CcSEcCtD
Tizanidine—Vomiting—Ezetimibe—coronary artery disease	6.36e-05	0.000247	CcSEcCtD
Tizanidine—Hypersensitivity—Pravastatin—coronary artery disease	6.35e-05	0.000247	CcSEcCtD
Tizanidine—Gastrointestinal pain—Perindopril—coronary artery disease	6.35e-05	0.000247	CcSEcCtD
Tizanidine—Anxiety—Timolol—coronary artery disease	6.35e-05	0.000247	CcSEcCtD
Tizanidine—Pruritus—Olmesartan—coronary artery disease	6.34e-05	0.000247	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	6.33e-05	0.000246	CcSEcCtD
Tizanidine—Body temperature increased—Captopril—coronary artery disease	6.32e-05	0.000246	CcSEcCtD
Tizanidine—Abdominal pain—Captopril—coronary artery disease	6.32e-05	0.000246	CcSEcCtD
Tizanidine—Dizziness—Simvastatin—coronary artery disease	6.31e-05	0.000245	CcSEcCtD
Tizanidine—Rash—Ezetimibe—coronary artery disease	6.31e-05	0.000245	CcSEcCtD
Tizanidine—Dermatitis—Ezetimibe—coronary artery disease	6.3e-05	0.000245	CcSEcCtD
Tizanidine—Confusional state—Ramipril—coronary artery disease	6.3e-05	0.000245	CcSEcCtD
Tizanidine—Discomfort—Timolol—coronary artery disease	6.29e-05	0.000245	CcSEcCtD
Tizanidine—Asthenia—Niacin—coronary artery disease	6.28e-05	0.000244	CcSEcCtD
Tizanidine—Fatigue—Losartan—coronary artery disease	6.28e-05	0.000244	CcSEcCtD
Tizanidine—Malaise—Lisinopril—coronary artery disease	6.26e-05	0.000243	CcSEcCtD
Tizanidine—Anaphylactic shock—Ramipril—coronary artery disease	6.25e-05	0.000243	CcSEcCtD
Tizanidine—Oedema—Ramipril—coronary artery disease	6.25e-05	0.000243	CcSEcCtD
Tizanidine—Vertigo—Lisinopril—coronary artery disease	6.24e-05	0.000242	CcSEcCtD
Tizanidine—Dry mouth—Timolol—coronary artery disease	6.23e-05	0.000242	CcSEcCtD
Tizanidine—Constipation—Losartan—coronary artery disease	6.23e-05	0.000242	CcSEcCtD
Tizanidine—Syncope—Lisinopril—coronary artery disease	6.22e-05	0.000242	CcSEcCtD
Tizanidine—Vomiting—Eplerenone—coronary artery disease	6.22e-05	0.000242	CcSEcCtD
Tizanidine—Feeling abnormal—Furosemide—coronary artery disease	6.22e-05	0.000242	CcSEcCtD
Tizanidine—Leukopenia—Lisinopril—coronary artery disease	6.21e-05	0.000242	CcSEcCtD
Tizanidine—Nausea—Fenofibrate—coronary artery disease	6.2e-05	0.000241	CcSEcCtD
Tizanidine—Pruritus—Niacin—coronary artery disease	6.2e-05	0.000241	CcSEcCtD
Tizanidine—Asthenia—Pravastatin—coronary artery disease	6.19e-05	0.00024	CcSEcCtD
Tizanidine—Gastrointestinal pain—Furosemide—coronary artery disease	6.17e-05	0.00024	CcSEcCtD
Tizanidine—Rash—Eplerenone—coronary artery disease	6.17e-05	0.00024	CcSEcCtD
Tizanidine—Urticaria—Perindopril—coronary artery disease	6.17e-05	0.00024	CcSEcCtD
Tizanidine—Hypersensitivity—Trandolapril—coronary artery disease	6.17e-05	0.00024	CcSEcCtD
Tizanidine—Dermatitis—Eplerenone—coronary artery disease	6.17e-05	0.00024	CcSEcCtD
Tizanidine—Diarrhoea—Valsartan—coronary artery disease	6.16e-05	0.00024	CcSEcCtD
Tizanidine—Confusional state—Timolol—coronary artery disease	6.16e-05	0.000239	CcSEcCtD
Tizanidine—Shock—Ramipril—coronary artery disease	6.14e-05	0.000239	CcSEcCtD
Tizanidine—Hypersensitivity—Enalapril—coronary artery disease	6.14e-05	0.000239	CcSEcCtD
Tizanidine—Body temperature increased—Perindopril—coronary artery disease	6.14e-05	0.000239	CcSEcCtD
Tizanidine—Abdominal pain—Perindopril—coronary artery disease	6.14e-05	0.000239	CcSEcCtD
Tizanidine—Diarrhoea—Olmesartan—coronary artery disease	6.13e-05	0.000238	CcSEcCtD
Tizanidine—Nervous system disorder—Ramipril—coronary artery disease	6.12e-05	0.000238	CcSEcCtD
Tizanidine—Thrombocytopenia—Ramipril—coronary artery disease	6.11e-05	0.000238	CcSEcCtD
Tizanidine—Anaphylactic shock—Timolol—coronary artery disease	6.11e-05	0.000237	CcSEcCtD
Tizanidine—Oedema—Timolol—coronary artery disease	6.11e-05	0.000237	CcSEcCtD
Tizanidine—Pruritus—Pravastatin—coronary artery disease	6.1e-05	0.000237	CcSEcCtD
Tizanidine—Loss of consciousness—Lisinopril—coronary artery disease	6.1e-05	0.000237	CcSEcCtD
Tizanidine—Nausea—Clopidogrel—coronary artery disease	6.1e-05	0.000237	CcSEcCtD
Tizanidine—Tachycardia—Ramipril—coronary artery disease	6.1e-05	0.000237	CcSEcCtD
Tizanidine—Skin disorder—Ramipril—coronary artery disease	6.07e-05	0.000236	CcSEcCtD
Tizanidine—Infection—Timolol—coronary artery disease	6.07e-05	0.000236	CcSEcCtD
Tizanidine—Vomiting—Simvastatin—coronary artery disease	6.06e-05	0.000236	CcSEcCtD
Tizanidine—Hypersensitivity—Telmisartan—coronary artery disease	6.06e-05	0.000236	CcSEcCtD
Tizanidine—Nausea—Lovastatin—coronary artery disease	6.06e-05	0.000235	CcSEcCtD
Tizanidine—Hyperhidrosis—Ramipril—coronary artery disease	6.04e-05	0.000235	CcSEcCtD
Tizanidine—Rash—Simvastatin—coronary artery disease	6.01e-05	0.000234	CcSEcCtD
Tizanidine—Dermatitis—Simvastatin—coronary artery disease	6.01e-05	0.000234	CcSEcCtD
Tizanidine—Asthenia—Trandolapril—coronary artery disease	6.01e-05	0.000234	CcSEcCtD
Tizanidine—Shock—Timolol—coronary artery disease	6.01e-05	0.000234	CcSEcCtD
Tizanidine—Feeling abnormal—Losartan—coronary artery disease	6e-05	0.000233	CcSEcCtD
Tizanidine—Urticaria—Furosemide—coronary artery disease	6e-05	0.000233	CcSEcCtD
Tizanidine—Diarrhoea—Niacin—coronary artery disease	5.99e-05	0.000233	CcSEcCtD
Tizanidine—Nervous system disorder—Timolol—coronary artery disease	5.99e-05	0.000233	CcSEcCtD
Tizanidine—Asthenia—Enalapril—coronary artery disease	5.98e-05	0.000233	CcSEcCtD
Tizanidine—Abdominal pain—Furosemide—coronary artery disease	5.97e-05	0.000232	CcSEcCtD
Tizanidine—Body temperature increased—Furosemide—coronary artery disease	5.97e-05	0.000232	CcSEcCtD
Tizanidine—Gastrointestinal pain—Losartan—coronary artery disease	5.96e-05	0.000232	CcSEcCtD
Tizanidine—Dizziness—Valsartan—coronary artery disease	5.96e-05	0.000232	CcSEcCtD
Tizanidine—Nausea—Ezetimibe—coronary artery disease	5.94e-05	0.000231	CcSEcCtD
Tizanidine—Skin disorder—Timolol—coronary artery disease	5.93e-05	0.000231	CcSEcCtD
Tizanidine—Dizziness—Olmesartan—coronary artery disease	5.93e-05	0.00023	CcSEcCtD
Tizanidine—Pruritus—Trandolapril—coronary artery disease	5.92e-05	0.00023	CcSEcCtD
Tizanidine—Arthralgia—Lisinopril—coronary artery disease	5.91e-05	0.00023	CcSEcCtD
Tizanidine—Hyperhidrosis—Timolol—coronary artery disease	5.9e-05	0.000229	CcSEcCtD
Tizanidine—Asthenia—Telmisartan—coronary artery disease	5.9e-05	0.000229	CcSEcCtD
Tizanidine—Pruritus—Enalapril—coronary artery disease	5.9e-05	0.000229	CcSEcCtD
Tizanidine—Diarrhoea—Pravastatin—coronary artery disease	5.9e-05	0.000229	CcSEcCtD
Tizanidine—Anxiety—Lisinopril—coronary artery disease	5.89e-05	0.000229	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.87e-05	0.000228	CcSEcCtD
Tizanidine—Discomfort—Lisinopril—coronary artery disease	5.84e-05	0.000227	CcSEcCtD
Tizanidine—Hypotension—Ramipril—coronary artery disease	5.84e-05	0.000227	CcSEcCtD
Tizanidine—Pruritus—Telmisartan—coronary artery disease	5.82e-05	0.000226	CcSEcCtD
Tizanidine—Nausea—Eplerenone—coronary artery disease	5.81e-05	0.000226	CcSEcCtD
Tizanidine—Dizziness—Niacin—coronary artery disease	5.79e-05	0.000225	CcSEcCtD
Tizanidine—Urticaria—Losartan—coronary artery disease	5.79e-05	0.000225	CcSEcCtD
Tizanidine—Dry mouth—Lisinopril—coronary artery disease	5.78e-05	0.000225	CcSEcCtD
Tizanidine—Abdominal pain—Losartan—coronary artery disease	5.76e-05	0.000224	CcSEcCtD
Tizanidine—Body temperature increased—Losartan—coronary artery disease	5.76e-05	0.000224	CcSEcCtD
Tizanidine—Asthenia—Captopril—coronary artery disease	5.74e-05	0.000223	CcSEcCtD
Tizanidine—Diarrhoea—Trandolapril—coronary artery disease	5.73e-05	0.000223	CcSEcCtD
Tizanidine—Vomiting—Valsartan—coronary artery disease	5.73e-05	0.000223	CcSEcCtD
Tizanidine—Confusional state—Lisinopril—coronary artery disease	5.71e-05	0.000222	CcSEcCtD
Tizanidine—Diarrhoea—Enalapril—coronary artery disease	5.71e-05	0.000222	CcSEcCtD
Tizanidine—Hypotension—Timolol—coronary artery disease	5.71e-05	0.000222	CcSEcCtD
Tizanidine—Dizziness—Pravastatin—coronary artery disease	5.7e-05	0.000222	CcSEcCtD
Tizanidine—Vomiting—Olmesartan—coronary artery disease	5.7e-05	0.000222	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.69e-05	0.000221	CcSEcCtD
Tizanidine—Rash—Valsartan—coronary artery disease	5.68e-05	0.000221	CcSEcCtD
Tizanidine—Dermatitis—Valsartan—coronary artery disease	5.67e-05	0.000221	CcSEcCtD
Tizanidine—Nausea—Simvastatin—coronary artery disease	5.66e-05	0.00022	CcSEcCtD
Tizanidine—Anaphylactic shock—Lisinopril—coronary artery disease	5.66e-05	0.00022	CcSEcCtD
Tizanidine—Oedema—Lisinopril—coronary artery disease	5.66e-05	0.00022	CcSEcCtD
Tizanidine—Pruritus—Captopril—coronary artery disease	5.66e-05	0.00022	CcSEcCtD
Tizanidine—Rash—Olmesartan—coronary artery disease	5.65e-05	0.00022	CcSEcCtD
Tizanidine—Dermatitis—Olmesartan—coronary artery disease	5.65e-05	0.00022	CcSEcCtD
Tizanidine—Diarrhoea—Telmisartan—coronary artery disease	5.63e-05	0.000219	CcSEcCtD
Tizanidine—Infection—Lisinopril—coronary artery disease	5.63e-05	0.000219	CcSEcCtD
Tizanidine—Paraesthesia—Ramipril—coronary artery disease	5.61e-05	0.000218	CcSEcCtD
Tizanidine—Shock—Lisinopril—coronary artery disease	5.57e-05	0.000217	CcSEcCtD
Tizanidine—Asthenia—Perindopril—coronary artery disease	5.57e-05	0.000217	CcSEcCtD
Tizanidine—Dyspnoea—Ramipril—coronary artery disease	5.57e-05	0.000216	CcSEcCtD
Tizanidine—Vomiting—Niacin—coronary artery disease	5.57e-05	0.000216	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Timolol—coronary artery disease	5.56e-05	0.000216	CcSEcCtD
Tizanidine—Hypersensitivity—Furosemide—coronary artery disease	5.56e-05	0.000216	CcSEcCtD
Tizanidine—Somnolence—Ramipril—coronary artery disease	5.55e-05	0.000216	CcSEcCtD
Tizanidine—Thrombocytopenia—Lisinopril—coronary artery disease	5.55e-05	0.000216	CcSEcCtD
Tizanidine—Dizziness—Trandolapril—coronary artery disease	5.54e-05	0.000215	CcSEcCtD
Tizanidine—Tachycardia—Lisinopril—coronary artery disease	5.53e-05	0.000215	CcSEcCtD
Tizanidine—Rash—Niacin—coronary artery disease	5.52e-05	0.000215	CcSEcCtD
Tizanidine—Dermatitis—Niacin—coronary artery disease	5.52e-05	0.000214	CcSEcCtD
Tizanidine—Dizziness—Enalapril—coronary artery disease	5.51e-05	0.000214	CcSEcCtD
Tizanidine—Skin disorder—Lisinopril—coronary artery disease	5.5e-05	0.000214	CcSEcCtD
Tizanidine—Dyspepsia—Ramipril—coronary artery disease	5.5e-05	0.000214	CcSEcCtD
Tizanidine—Pruritus—Perindopril—coronary artery disease	5.49e-05	0.000214	CcSEcCtD
Tizanidine—Paraesthesia—Timolol—coronary artery disease	5.48e-05	0.000213	CcSEcCtD
Tizanidine—Vomiting—Pravastatin—coronary artery disease	5.48e-05	0.000213	CcSEcCtD
Tizanidine—Hyperhidrosis—Lisinopril—coronary artery disease	5.48e-05	0.000213	CcSEcCtD
Tizanidine—Diarrhoea—Captopril—coronary artery disease	5.47e-05	0.000213	CcSEcCtD
Tizanidine—Dyspnoea—Timolol—coronary artery disease	5.44e-05	0.000212	CcSEcCtD
Tizanidine—Dizziness—Telmisartan—coronary artery disease	5.44e-05	0.000211	CcSEcCtD
Tizanidine—Rash—Pravastatin—coronary artery disease	5.44e-05	0.000211	CcSEcCtD
Tizanidine—Dermatitis—Pravastatin—coronary artery disease	5.43e-05	0.000211	CcSEcCtD
Tizanidine—Somnolence—Timolol—coronary artery disease	5.43e-05	0.000211	CcSEcCtD
Tizanidine—Asthenia—Furosemide—coronary artery disease	5.42e-05	0.000211	CcSEcCtD
Tizanidine—Fatigue—Ramipril—coronary artery disease	5.38e-05	0.000209	CcSEcCtD
Tizanidine—Dyspepsia—Timolol—coronary artery disease	5.37e-05	0.000209	CcSEcCtD
Tizanidine—Hypersensitivity—Losartan—coronary artery disease	5.37e-05	0.000209	CcSEcCtD
Tizanidine—Nausea—Valsartan—coronary artery disease	5.35e-05	0.000208	CcSEcCtD
Tizanidine—Pruritus—Furosemide—coronary artery disease	5.34e-05	0.000208	CcSEcCtD
Tizanidine—Constipation—Ramipril—coronary artery disease	5.34e-05	0.000208	CcSEcCtD
Tizanidine—Nausea—Olmesartan—coronary artery disease	5.32e-05	0.000207	CcSEcCtD
Tizanidine—Vomiting—Trandolapril—coronary artery disease	5.32e-05	0.000207	CcSEcCtD
Tizanidine—Diarrhoea—Perindopril—coronary artery disease	5.31e-05	0.000207	CcSEcCtD
Tizanidine—Vomiting—Enalapril—coronary artery disease	5.3e-05	0.000206	CcSEcCtD
Tizanidine—Hypotension—Lisinopril—coronary artery disease	5.29e-05	0.000206	CcSEcCtD
Tizanidine—Dizziness—Captopril—coronary artery disease	5.29e-05	0.000206	CcSEcCtD
Tizanidine—Rash—Trandolapril—coronary artery disease	5.28e-05	0.000205	CcSEcCtD
Tizanidine—Dermatitis—Trandolapril—coronary artery disease	5.27e-05	0.000205	CcSEcCtD
Tizanidine—Fatigue—Timolol—coronary artery disease	5.26e-05	0.000205	CcSEcCtD
Tizanidine—Rash—Enalapril—coronary artery disease	5.26e-05	0.000204	CcSEcCtD
Tizanidine—Dermatitis—Enalapril—coronary artery disease	5.25e-05	0.000204	CcSEcCtD
Tizanidine—Vomiting—Telmisartan—coronary artery disease	5.23e-05	0.000203	CcSEcCtD
Tizanidine—Asthenia—Losartan—coronary artery disease	5.23e-05	0.000203	CcSEcCtD
Tizanidine—Nausea—Niacin—coronary artery disease	5.2e-05	0.000202	CcSEcCtD
Tizanidine—Rash—Telmisartan—coronary artery disease	5.19e-05	0.000202	CcSEcCtD
Tizanidine—Dermatitis—Telmisartan—coronary artery disease	5.18e-05	0.000201	CcSEcCtD
Tizanidine—Diarrhoea—Furosemide—coronary artery disease	5.16e-05	0.000201	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.16e-05	0.000201	CcSEcCtD
Tizanidine—Pruritus—Losartan—coronary artery disease	5.15e-05	0.0002	CcSEcCtD
Tizanidine—Feeling abnormal—Ramipril—coronary artery disease	5.15e-05	0.0002	CcSEcCtD
Tizanidine—Dizziness—Perindopril—coronary artery disease	5.13e-05	0.0002	CcSEcCtD
Tizanidine—Nausea—Pravastatin—coronary artery disease	5.12e-05	0.000199	CcSEcCtD
Tizanidine—Gastrointestinal pain—Ramipril—coronary artery disease	5.11e-05	0.000199	CcSEcCtD
Tizanidine—Paraesthesia—Lisinopril—coronary artery disease	5.09e-05	0.000198	CcSEcCtD
Tizanidine—Vomiting—Captopril—coronary artery disease	5.09e-05	0.000198	CcSEcCtD
Tizanidine—Dyspnoea—Lisinopril—coronary artery disease	5.05e-05	0.000196	CcSEcCtD
Tizanidine—Rash—Captopril—coronary artery disease	5.04e-05	0.000196	CcSEcCtD
Tizanidine—Dermatitis—Captopril—coronary artery disease	5.04e-05	0.000196	CcSEcCtD
Tizanidine—Somnolence—Lisinopril—coronary artery disease	5.04e-05	0.000196	CcSEcCtD
Tizanidine—Feeling abnormal—Timolol—coronary artery disease	5.03e-05	0.000196	CcSEcCtD
Tizanidine—Gastrointestinal pain—Timolol—coronary artery disease	4.99e-05	0.000194	CcSEcCtD
Tizanidine—Dizziness—Furosemide—coronary artery disease	4.99e-05	0.000194	CcSEcCtD
Tizanidine—Dyspepsia—Lisinopril—coronary artery disease	4.99e-05	0.000194	CcSEcCtD
Tizanidine—Diarrhoea—Losartan—coronary artery disease	4.98e-05	0.000194	CcSEcCtD
Tizanidine—Nausea—Trandolapril—coronary artery disease	4.97e-05	0.000193	CcSEcCtD
Tizanidine—Urticaria—Ramipril—coronary artery disease	4.96e-05	0.000193	CcSEcCtD
Tizanidine—Nausea—Enalapril—coronary artery disease	4.95e-05	0.000193	CcSEcCtD
Tizanidine—Vomiting—Perindopril—coronary artery disease	4.94e-05	0.000192	CcSEcCtD
Tizanidine—Abdominal pain—Ramipril—coronary artery disease	4.94e-05	0.000192	CcSEcCtD
Tizanidine—Body temperature increased—Ramipril—coronary artery disease	4.94e-05	0.000192	CcSEcCtD
Tizanidine—Rash—Perindopril—coronary artery disease	4.9e-05	0.00019	CcSEcCtD
Tizanidine—Dermatitis—Perindopril—coronary artery disease	4.89e-05	0.00019	CcSEcCtD
Tizanidine—Nausea—Telmisartan—coronary artery disease	4.89e-05	0.00019	CcSEcCtD
Tizanidine—Fatigue—Lisinopril—coronary artery disease	4.88e-05	0.00019	CcSEcCtD
Tizanidine—Urticaria—Timolol—coronary artery disease	4.85e-05	0.000189	CcSEcCtD
Tizanidine—Constipation—Lisinopril—coronary artery disease	4.84e-05	0.000188	CcSEcCtD
Tizanidine—Body temperature increased—Timolol—coronary artery disease	4.83e-05	0.000188	CcSEcCtD
Tizanidine—Abdominal pain—Timolol—coronary artery disease	4.83e-05	0.000188	CcSEcCtD
Tizanidine—Dizziness—Losartan—coronary artery disease	4.82e-05	0.000187	CcSEcCtD
Tizanidine—Vomiting—Furosemide—coronary artery disease	4.8e-05	0.000187	CcSEcCtD
Tizanidine—Rash—Furosemide—coronary artery disease	4.76e-05	0.000185	CcSEcCtD
Tizanidine—Dermatitis—Furosemide—coronary artery disease	4.76e-05	0.000185	CcSEcCtD
Tizanidine—Nausea—Captopril—coronary artery disease	4.75e-05	0.000185	CcSEcCtD
Tizanidine—Feeling abnormal—Lisinopril—coronary artery disease	4.67e-05	0.000181	CcSEcCtD
Tizanidine—Gastrointestinal pain—Lisinopril—coronary artery disease	4.63e-05	0.00018	CcSEcCtD
Tizanidine—Vomiting—Losartan—coronary artery disease	4.63e-05	0.00018	CcSEcCtD
Tizanidine—Nausea—Perindopril—coronary artery disease	4.61e-05	0.000179	CcSEcCtD
Tizanidine—Hypersensitivity—Ramipril—coronary artery disease	4.6e-05	0.000179	CcSEcCtD
Tizanidine—Rash—Losartan—coronary artery disease	4.59e-05	0.000179	CcSEcCtD
Tizanidine—Dermatitis—Losartan—coronary artery disease	4.59e-05	0.000178	CcSEcCtD
Tizanidine—Urticaria—Lisinopril—coronary artery disease	4.5e-05	0.000175	CcSEcCtD
Tizanidine—Hypersensitivity—Timolol—coronary artery disease	4.5e-05	0.000175	CcSEcCtD
Tizanidine—Nausea—Furosemide—coronary artery disease	4.48e-05	0.000174	CcSEcCtD
Tizanidine—Asthenia—Ramipril—coronary artery disease	4.48e-05	0.000174	CcSEcCtD
Tizanidine—Abdominal pain—Lisinopril—coronary artery disease	4.48e-05	0.000174	CcSEcCtD
Tizanidine—Body temperature increased—Lisinopril—coronary artery disease	4.48e-05	0.000174	CcSEcCtD
Tizanidine—Pruritus—Ramipril—coronary artery disease	4.42e-05	0.000172	CcSEcCtD
Tizanidine—Asthenia—Timolol—coronary artery disease	4.38e-05	0.00017	CcSEcCtD
Tizanidine—Nausea—Losartan—coronary artery disease	4.33e-05	0.000168	CcSEcCtD
Tizanidine—Pruritus—Timolol—coronary artery disease	4.32e-05	0.000168	CcSEcCtD
Tizanidine—Diarrhoea—Ramipril—coronary artery disease	4.27e-05	0.000166	CcSEcCtD
Tizanidine—Diarrhoea—Timolol—coronary artery disease	4.18e-05	0.000162	CcSEcCtD
Tizanidine—Hypersensitivity—Lisinopril—coronary artery disease	4.17e-05	0.000162	CcSEcCtD
Tizanidine—Dizziness—Ramipril—coronary artery disease	4.13e-05	0.000161	CcSEcCtD
Tizanidine—Asthenia—Lisinopril—coronary artery disease	4.06e-05	0.000158	CcSEcCtD
Tizanidine—Dizziness—Timolol—coronary artery disease	4.04e-05	0.000157	CcSEcCtD
Tizanidine—Pruritus—Lisinopril—coronary artery disease	4.01e-05	0.000156	CcSEcCtD
Tizanidine—Vomiting—Ramipril—coronary artery disease	3.97e-05	0.000154	CcSEcCtD
Tizanidine—Rash—Ramipril—coronary artery disease	3.94e-05	0.000153	CcSEcCtD
Tizanidine—Dermatitis—Ramipril—coronary artery disease	3.93e-05	0.000153	CcSEcCtD
Tizanidine—Vomiting—Timolol—coronary artery disease	3.88e-05	0.000151	CcSEcCtD
Tizanidine—Diarrhoea—Lisinopril—coronary artery disease	3.88e-05	0.000151	CcSEcCtD
Tizanidine—Rash—Timolol—coronary artery disease	3.85e-05	0.00015	CcSEcCtD
Tizanidine—Dermatitis—Timolol—coronary artery disease	3.85e-05	0.00015	CcSEcCtD
Tizanidine—Dizziness—Lisinopril—coronary artery disease	3.75e-05	0.000146	CcSEcCtD
Tizanidine—Nausea—Ramipril—coronary artery disease	3.71e-05	0.000144	CcSEcCtD
Tizanidine—Nausea—Timolol—coronary artery disease	3.63e-05	0.000141	CcSEcCtD
Tizanidine—Vomiting—Lisinopril—coronary artery disease	3.6e-05	0.00014	CcSEcCtD
Tizanidine—Rash—Lisinopril—coronary artery disease	3.57e-05	0.000139	CcSEcCtD
Tizanidine—Dermatitis—Lisinopril—coronary artery disease	3.57e-05	0.000139	CcSEcCtD
Tizanidine—Nausea—Lisinopril—coronary artery disease	3.36e-05	0.000131	CcSEcCtD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.7e-06	8.15e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CSF2—coronary artery disease	7.69e-06	8.13e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGF1—coronary artery disease	7.69e-06	8.13e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PPP2CA—coronary artery disease	7.67e-06	8.11e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOE—coronary artery disease	7.65e-06	8.09e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LPL—coronary artery disease	7.63e-06	8.07e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.62e-06	8.06e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ITGAV—coronary artery disease	7.61e-06	8.04e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TGFB1—coronary artery disease	7.59e-06	8.03e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KNG1—coronary artery disease	7.58e-06	8.02e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RPS6KB1—coronary artery disease	7.57e-06	8e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MEF2C—coronary artery disease	7.57e-06	8e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOA1—coronary artery disease	7.56e-06	8e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—POMC—coronary artery disease	7.56e-06	7.99e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CREB1—coronary artery disease	7.56e-06	7.99e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTM1—coronary artery disease	7.55e-06	7.99e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGTR1—coronary artery disease	7.54e-06	7.97e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PRKCD—coronary artery disease	7.53e-06	7.96e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—MAPK1—coronary artery disease	7.45e-06	7.88e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—LPL—coronary artery disease	7.42e-06	7.84e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCL2—coronary artery disease	7.4e-06	7.82e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6R—coronary artery disease	7.37e-06	7.8e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ITGB3—coronary artery disease	7.37e-06	7.8e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR2A—coronary artery disease	7.37e-06	7.79e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL10—coronary artery disease	7.37e-06	7.79e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—C3—coronary artery disease	7.36e-06	7.78e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PLG—coronary artery disease	7.35e-06	7.77e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—VCAN—coronary artery disease	7.35e-06	7.77e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDOA—coronary artery disease	7.29e-06	7.71e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GPX1—coronary artery disease	7.23e-06	7.65e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL8—coronary artery disease	7.2e-06	7.61e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PPP2CA—coronary artery disease	7.16e-06	7.58e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRB2—coronary artery disease	7.15e-06	7.56e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—DCN—coronary artery disease	7.08e-06	7.48e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCE—coronary artery disease	7.06e-06	7.47e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—JAK2—coronary artery disease	7.05e-06	7.46e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CD36—coronary artery disease	7.05e-06	7.45e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SOCS1—coronary artery disease	7.04e-06	7.45e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRKCD—coronary artery disease	7.03e-06	7.44e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—S100B—coronary artery disease	7.03e-06	7.43e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HIF1A—coronary artery disease	7.02e-06	7.42e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGT—coronary artery disease	6.99e-06	7.39e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—coronary artery disease	6.96e-06	7.36e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPP2CA—coronary artery disease	6.96e-06	7.36e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SOCS3—coronary artery disease	6.96e-06	7.36e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDH2—coronary artery disease	6.88e-06	7.28e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR2A—coronary artery disease	6.88e-06	7.28e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KITLG—coronary artery disease	6.87e-06	7.27e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFBR2—coronary artery disease	6.87e-06	7.27e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—C3—coronary artery disease	6.87e-06	7.27e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOE—coronary artery disease	6.85e-06	7.25e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LEP—coronary artery disease	6.85e-06	7.25e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOA1—coronary artery disease	6.77e-06	7.16e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT5A—coronary artery disease	6.72e-06	7.11e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP3—coronary artery disease	6.72e-06	7.11e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KDR—coronary artery disease	6.71e-06	7.1e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.71e-06	7.1e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LIPC—coronary artery disease	6.71e-06	7.09e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2C19—coronary artery disease	6.71e-06	7.09e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	6.71e-06	7.09e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HBA1—coronary artery disease	6.71e-06	7.09e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MTHFR—coronary artery disease	6.68e-06	7.06e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK14—coronary artery disease	6.67e-06	7.05e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOC3—coronary artery disease	6.67e-06	7.05e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—coronary artery disease	6.67e-06	7.05e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LDLR—coronary artery disease	6.63e-06	7.01e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.62e-06	7e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—POMC—coronary artery disease	6.57e-06	6.95e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HIF1A—coronary artery disease	6.55e-06	6.93e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC9A1—coronary artery disease	6.55e-06	6.92e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTT1—coronary artery disease	6.55e-06	6.92e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ESR1—coronary artery disease	6.54e-06	6.92e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGT—coronary artery disease	6.53e-06	6.91e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—coronary artery disease	6.5e-06	6.87e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOB—coronary artery disease	6.49e-06	6.87e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GCLC—coronary artery disease	6.47e-06	6.85e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CETP—coronary artery disease	6.47e-06	6.85e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CA—coronary artery disease	6.46e-06	6.84e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FN1—coronary artery disease	6.46e-06	6.83e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—F2—coronary artery disease	6.46e-06	6.83e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL8—coronary artery disease	6.44e-06	6.81e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6ST—coronary artery disease	6.43e-06	6.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—JAK2—coronary artery disease	6.41e-06	6.78e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SDC1—coronary artery disease	6.4e-06	6.77e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOE—coronary artery disease	6.4e-06	6.77e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LEP—coronary artery disease	6.4e-06	6.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EDN1—coronary artery disease	6.39e-06	6.76e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NFKBIA—coronary artery disease	6.38e-06	6.75e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AGT—coronary artery disease	6.34e-06	6.71e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL5—coronary artery disease	6.34e-06	6.71e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOA1—coronary artery disease	6.33e-06	6.69e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KDR—coronary artery disease	6.27e-06	6.63e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CSF2—coronary artery disease	6.25e-06	6.61e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGF1—coronary artery disease	6.25e-06	6.61e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK14—coronary artery disease	6.23e-06	6.59e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOE—coronary artery disease	6.22e-06	6.57e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LPL—coronary artery disease	6.2e-06	6.56e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KIT—coronary artery disease	6.18e-06	6.54e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RPS6KB1—coronary artery disease	6.15e-06	6.5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MEF2C—coronary artery disease	6.15e-06	6.5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOA1—coronary artery disease	6.14e-06	6.5e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ESR1—coronary artery disease	6.11e-06	6.46e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PSMA6—coronary artery disease	6.05e-06	6.39e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PSMB5—coronary artery disease	6.05e-06	6.39e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—F2—coronary artery disease	6.03e-06	6.38e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FN1—coronary artery disease	6.03e-06	6.38e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	6.03e-06	6.38e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6ST—coronary artery disease	6.01e-06	6.36e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—coronary artery disease	5.99e-06	6.34e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	5.99e-06	6.33e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NFKBIA—coronary artery disease	5.96e-06	6.31e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GSK3B—coronary artery disease	5.93e-06	6.27e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CTGF—coronary artery disease	5.91e-06	6.25e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—POMC—coronary artery disease	5.88e-06	6.22e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CREB1—coronary artery disease	5.88e-06	6.22e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMGCR—coronary artery disease	5.85e-06	6.19e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GOT2—coronary artery disease	5.85e-06	6.19e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	5.85e-06	6.18e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	5.82e-06	6.15e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KIT—coronary artery disease	5.77e-06	6.11e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCL2—coronary artery disease	5.76e-06	6.09e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6R—coronary artery disease	5.74e-06	6.07e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—NOS3—coronary artery disease	5.73e-06	6.06e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	5.71e-06	6.04e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF1—coronary artery disease	5.66e-06	5.99e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—MAPK1—coronary artery disease	5.63e-06	5.96e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	5.59e-06	5.91e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—C3—coronary artery disease	5.58e-06	5.9e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GSK3B—coronary artery disease	5.54e-06	5.86e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CREB1—coronary artery disease	5.5e-06	5.81e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—POMC—coronary artery disease	5.5e-06	5.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—coronary artery disease	5.41e-06	5.73e-05	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CA—coronary artery disease	5.38e-06	5.69e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PLCB1—coronary artery disease	5.38e-06	5.69e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCL2—coronary artery disease	5.38e-06	5.69e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SERPINE1—coronary artery disease	5.38e-06	5.69e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6R—coronary artery disease	5.36e-06	5.67e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—POMC—coronary artery disease	5.34e-06	5.65e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	5.32e-06	5.63e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGT—coronary artery disease	5.3e-06	5.61e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF1—coronary artery disease	5.29e-06	5.59e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—coronary artery disease	5.28e-06	5.58e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.28e-06	5.58e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—MAPK1—coronary artery disease	5.26e-06	5.57e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—coronary artery disease	5.24e-06	5.55e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ABCA1—coronary artery disease	5.22e-06	5.52e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGF2—coronary artery disease	5.2e-06	5.5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LEP—coronary artery disease	5.2e-06	5.5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOE—coronary artery disease	5.2e-06	5.5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	5.14e-06	5.43e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOS3—coronary artery disease	5.13e-06	5.43e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KDR—coronary artery disease	5.09e-06	5.39e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	5.06e-06	5.35e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GOT1—coronary artery disease	5.05e-06	5.34e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GGT1—coronary artery disease	5.05e-06	5.34e-05	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CA—coronary artery disease	5.03e-06	5.32e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SERPINE1—coronary artery disease	5.02e-06	5.31e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	4.99e-06	5.28e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	4.96e-06	5.25e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—F2—coronary artery disease	4.9e-06	5.18e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	4.9e-06	5.18e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	4.89e-06	5.17e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	4.88e-06	5.16e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—coronary artery disease	4.87e-06	5.15e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGF2—coronary artery disease	4.86e-06	5.14e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	4.84e-06	5.12e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOS3—coronary artery disease	4.79e-06	5.07e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	4.69e-06	4.96e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	4.66e-06	4.93e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NOS3—coronary artery disease	4.66e-06	4.93e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	4.57e-06	4.83e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	4.55e-06	4.81e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTP1—coronary artery disease	4.54e-06	4.8e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	4.5e-06	4.76e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	4.5e-06	4.76e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMOX1—coronary artery disease	4.48e-06	4.73e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	4.46e-06	4.72e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	4.46e-06	4.72e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CAT—coronary artery disease	4.42e-06	4.67e-05	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	4.4e-06	4.65e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	4.37e-06	4.62e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	4.36e-06	4.61e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	4.36e-06	4.61e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	4.33e-06	4.58e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	4.29e-06	4.54e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOB—coronary artery disease	4.29e-06	4.53e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	4.27e-06	4.52e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—coronary artery disease	4.26e-06	4.5e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	4.25e-06	4.5e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	4.24e-06	4.49e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTM1—coronary artery disease	4.17e-06	4.41e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	4.12e-06	4.35e-05	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	4.11e-06	4.34e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LPL—coronary artery disease	4.09e-06	4.33e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.08e-06	4.32e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	4.08e-06	4.31e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	4.07e-06	4.3e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	4.04e-06	4.28e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GPX1—coronary artery disease	3.99e-06	4.22e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	3.99e-06	4.22e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	3.96e-06	4.19e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	3.95e-06	4.18e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	3.89e-06	4.12e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CD36—coronary artery disease	3.89e-06	4.11e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	3.85e-06	4.07e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	3.84e-06	4.06e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	3.78e-06	4e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	3.73e-06	3.95e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	3.71e-06	3.92e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	3.7e-06	3.91e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTHFR—coronary artery disease	3.69e-06	3.9e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AGT—coronary artery disease	3.5e-06	3.7e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	3.45e-06	3.65e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	3.45e-06	3.65e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOE—coronary artery disease	3.43e-06	3.63e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	3.39e-06	3.59e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOA1—coronary artery disease	3.39e-06	3.59e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	3.34e-06	3.53e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	3.33e-06	3.52e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	3.31e-06	3.5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	3.28e-06	3.47e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.25e-06	3.44e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	3.23e-06	3.41e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	3.22e-06	3.4e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	3.17e-06	3.35e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	3.12e-06	3.3e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	3.11e-06	3.29e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	3.03e-06	3.2e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—coronary artery disease	2.99e-06	3.16e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—POMC—coronary artery disease	2.95e-06	3.12e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	2.89e-06	3.05e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	2.81e-06	2.97e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	2.7e-06	2.85e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—coronary artery disease	2.69e-06	2.84e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—coronary artery disease	2.64e-06	2.79e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	2.62e-06	2.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	2.57e-06	2.72e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NOS3—coronary artery disease	2.57e-06	2.72e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	2.56e-06	2.7e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	2.52e-06	2.67e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	2.39e-06	2.53e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	2.36e-06	2.5e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—coronary artery disease	2.35e-06	2.49e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	2.2e-06	2.33e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	2.19e-06	2.32e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—coronary artery disease	2.14e-06	2.26e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	1.94e-06	2.05e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	1.79e-06	1.89e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.45e-06	1.53e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—coronary artery disease	1.18e-06	1.25e-05	CbGpPWpGaD
